STOCK TITAN

Thermo Fisher Scientific, Inc. - TMO STOCK NEWS

Welcome to our dedicated page for Thermo Fisher Scientific news (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fisher Scientific stock.

Thermo Fisher Scientific, Inc. (TMO) is a global leader in providing science-based solutions, offering a wide range of products and services in the life sciences, analytical instruments, specialty diagnostics, and laboratory products sectors. The company's expansive portfolio includes scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents, serving customers both in the United States and internationally.

Thermo Fisher operates through four distinct segments as of end-2023:

  • Analytical Technologies (17% of sales): This segment focuses on providing high-quality instruments and software solutions for various scientific applications.
  • Specialty Diagnostic Products (10% of sales): This segment specializes in offering diagnostic reagents and instruments for medical and research laboratories.
  • Life Science Solutions (23% of sales): This segment provides reagents, instruments, and consumables used in biological research and drug development.
  • Lab Products and Services (54% of sales): This is the largest segment, encompassing laboratory supplies, equipment, and contract research organization (CRO) services.

Thermo Fisher is continually expanding its offerings and capabilities through strategic partnerships, acquisitions, and technological innovation. The company's robust financial performance underscores its leadership in the industry, driven by consistent revenue growth, strong market presence, and a commitment to advancing scientific research and healthcare.

Recent achievements include technological advancements in analytical instruments, enhanced diagnostic solutions, and expanded biopharma services, reflecting Thermo Fisher's dedication to supporting life-saving research and diagnostic processes. Thermo Fisher remains committed to delivering high-quality products and services, fostering scientific breakthroughs, and maintaining its position at the forefront of scientific innovation.

Rhea-AI Summary
ViroCell Biologics appoints Traci Kyes as VP of Business Development (US) and Makis Sigalas as Senior Business Development Director (Europe) to drive growth in respective regions
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
none
-
Rhea-AI Summary
Thermo Fisher Scientific will release its Q3 2023 financial results on October 25, 2023, and hold a conference call at 8:30 a.m. EDT. Investors can listen to the call on the company's website. A replay will be available until November 10, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific and the National Minority Quality Forum collaborate to increase diversity in clinical trials and improve health equity
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
Rhea-AI Summary
Thermo Fisher Scientific CEO to present at Morgan Stanley conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences
-
Rhea-AI Summary
Thermo Fisher Scientific CEO to present at Handelsbanken Life Science Innovation Day
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences
-
Rhea-AI Summary
Audax Private Equity has completed the sale of CorEvitas, a leading provider of real-world evidence for medical treatments, to Thermo Fisher Scientific. CorEvitas leverages proprietary data to help pharmaceutical customers uncover clinical insights. Under Audax's ownership, CorEvitas completed five add-on acquisitions and launched six new clinical registries. Audax has raised $5.25 billion for its seventh flagship fund and $774 million for its debut lower middle market strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. has priced an offering of $2.95 billion aggregate principal amount of senior notes. The offering includes $600 million of 4.953% senior notes due 2026, $750 million of 4.977% senior notes due 2030, $1 billion of 5.086% senior notes due 2033, and $600 million of 5.404% senior notes due 2043. The offering is expected to close soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
none
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) reported Q2 2023 revenue of $10.69 billion, a 3% decline YoY, with core organic revenue growth at 2%. GAAP diluted EPS was $3.51, while adjusted EPS was $5.15. The company announced a definitive agreement to acquire CorEvitas for approximately $0.9 billion and revised 2023 revenue guidance to $43.4 billion to $44.0 billion, with adjusted EPS of $22.28 to $22.72.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
dividends

FAQ

What is the current stock price of Thermo Fisher Scientific (TMO)?

The current stock price of Thermo Fisher Scientific (TMO) is $528.98 as of December 24, 2024.

What is the market cap of Thermo Fisher Scientific (TMO)?

The market cap of Thermo Fisher Scientific (TMO) is approximately 202.3B.

What does Thermo Fisher Scientific, Inc. specialize in?

Thermo Fisher Scientific specializes in life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.

What are the main segments of Thermo Fisher Scientific?

The main segments are Analytical Technologies, Specialty Diagnostic Products, Life Science Solutions, and Lab Products and Services.

How much of Thermo Fisher's sales come from Lab Products and Services?

Lab Products and Services account for 54% of Thermo Fisher's sales.

Where does Thermo Fisher Scientific operate?

Thermo Fisher Scientific operates both in the United States and internationally.

What recent achievements has Thermo Fisher Scientific made?

Recent achievements include advancements in analytical instruments, enhanced diagnostic solutions, and expanded biopharma services.

What is Thermo Fisher Scientific's stock symbol?

The stock symbol for Thermo Fisher Scientific is TMO.

How does Thermo Fisher Scientific support scientific research?

Thermo Fisher supports scientific research by providing high-quality instruments, reagents, and consumables essential for biological research and drug development.

What types of products does Thermo Fisher Scientific offer?

Thermo Fisher offers scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents.

What is Thermo Fisher's commitment to the healthcare industry?

Thermo Fisher is committed to advancing scientific research and healthcare by delivering high-quality products, fostering scientific breakthroughs, and supporting life-saving research and diagnostic processes.

What sets Thermo Fisher Scientific apart in its industry?

Thermo Fisher's leadership stems from its diverse portfolio, strategic partnerships, technological innovation, and consistent financial performance.

Thermo Fisher Scientific, Inc.

NYSE:TMO

TMO Rankings

TMO Stock Data

202.33B
381.74M
0.17%
90.93%
0.84%
Diagnostics & Research
Measuring & Controlling Devices, Nec
Link
United States of America
WALTHAM